Loading...
Prenetics Global Limited
PRE•NASDAQ
Healthcare
Medical - Diagnostics & Research
$8.06
$0.00(0.00%)
Prenetics Global Limited (PRE) Financial Performance & Income Statement Overview
Review Prenetics Global Limited’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
40.83%
↑ 40.83%
Operating Income Growth
7.25%
↑ 7.25%
Net Income Growth
26.18%
↑ 26.18%
Operating Cash Flow Growth
-109.77%
↓ 109.77%
Operating Margin
-119.50%
↓ 119.50%
Gross Margin
45.66%
↑ 45.66%
Net Profit Margin
-115.91%
↓ 115.91%
ROE
-27.57%
↓ 27.57%
ROIC
-29.83%
↓ 29.83%
Prenetics Global Limited (PRE) Income Statement & Financial Overview
Review Prenetics Global Limited's (PRE) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $10.49M | $7.78M | $5.94M | $6.41M |
| Cost of Revenue | $6.59M | $3.83M | $2.17M | $2.63M |
| Gross Profit | $3.90M | $3.95M | $3.77M | $3.78M |
| Gross Profit Ratio | $0.37 | $0.51 | $0.63 | $0.59 |
| R&D Expenses | $2.58M | $2.59M | $3.03M | $2.73M |
| SG&A Expenses | $19.18M | $13.12M | $12.10M | $10.96M |
| Operating Expenses | $20.47M | $15.76M | $14.38M | $13.69M |
| Total Costs & Expenses | $27.06M | $19.59M | $16.55M | $16.32M |
| Interest Income | $2.04M | $0.00 | $0.00 | $0.00 |
| Interest Expense | $78630.00 | $80552.00 | $27479.00 | $16339.00 |
| Depreciation & Amortization | $0.00 | $0.00 | $1.10M | $1.72M |
| EBITDA | -$24.89M | -$12.03M | -$9.51M | -$8.19M |
| EBITDA Ratio | -$2.37 | -$1.55 | -$1.60 | -$1.28 |
| Operating Income | -$16.57M | -$11.81M | -$10.61M | -$9.91M |
| Operating Income Ratio | -$1.58 | -$1.52 | -$1.79 | -$1.54 |
| Other Income/Expenses (Net) | -$8.40M | -$304854.00 | -$700171.00 | $595897.00 |
| Income Before Tax | -$24.97M | -$12.11M | -$11.31M | -$9.09M |
| Income Before Tax Ratio | -$2.38 | -$1.56 | -$1.90 | -$1.42 |
| Income Tax Expense | -$7.42M | -$75307.00 | -$89234.00 | -$285938.00 |
| Net Income | -$16.34M | -$10.67M | -$10.72M | -$8.57M |
| Net Income Ratio | -$1.56 | -$1.37 | -$1.80 | -$1.34 |
| EPS | $0.00 | -$0.84 | -$0.88 | -$0.70 |
| Diluted EPS | $0.00 | -$0.84 | -$0.88 | -$0.70 |
| Weighted Avg Shares Outstanding | $12.71M | $12.71M | $12.22M | $12.22M |
| Weighted Avg Shares Outstanding (Diluted) | $12.71M | $12.72M | $12.22M | $12.22M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan